Meteora Capital, LLC Sab Biotherapeutics, Inc. Transaction History

Meteora Capital, LLC

  • $328 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$0.54 - $9.8 $62,100 - $1.13 Million
-115,001 Reduced 46.09%
134,524 $79,000
Q3 2022

Nov 14, 2022
SELL
$0.13 - $12.4 $5,591 - $533,361
-43,013 Reduced 14.7%
249,525 $175,000
Q2 2022

Aug 15, 2022
BUY
$1.11 - $3.46 $324,717 - $1.01 Million
292,538 New
292,538 $424,000

Others Institutions Holding SABS

# of Institutions
3
Shares Held
529K
Call Options Held
0
Put Options Held
0
View Full List

About SAB Biotherapeutics, Inc.

SABS Quotes by TradingView
  • Ticker SABS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,030,900
  • Market Cap $111M
  • Description
  • SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies based on human antibodies. It has applied advanced genetic engineering and antibody science to develop transchromosomic bovine herds that produce fully human antibodies targeted at specific diseases, including infectious diseases ...
More about SABS
Track This Portfolio

Track Meteora Capital, LLC Portfolio

Follow Meteora Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meteora Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Meteora Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email